BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 16160027)

  • 1. In FMD, NO is actually "the middle man".
    Wray DW; Richardson RS
    J Appl Physiol (1985); 2005 Oct; 99(4):1624. PubMed ID: 16160027
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow-mediated vasodilation partially reflects nitric oxide-mediated endothelial function.
    Linke A; Erbs S; Hambrecht R
    J Appl Physiol (1985); 2005 Oct; 99(4):1622. PubMed ID: 16160025
    [No Abstract]   [Full Text] [Related]  

  • 3. Brachial artery FMD with 5-minute distal cuff occlusion--a useful pathophysiological test after all!
    Celermajer DS
    J Appl Physiol (1985); 2005 Oct; 99(4):1619. PubMed ID: 16160022
    [No Abstract]   [Full Text] [Related]  

  • 4. Flow-mediated vasodilation is mediated by endothelium-derived nitric oxide.
    Creager MA
    J Appl Physiol (1985); 2005 Oct; 99(4):1625. PubMed ID: 16160028
    [No Abstract]   [Full Text] [Related]  

  • 5. FMD vs. pharmacological approaches for endothelial function.
    Tanaka H
    J Appl Physiol (1985); 2005 Oct; 99(4):1627. PubMed ID: 16160030
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow-mediated dilation.
    Parker BA; Proctor DN
    J Appl Physiol (1985); 2005 Oct; 99(4):1620. PubMed ID: 16160023
    [No Abstract]   [Full Text] [Related]  

  • 7. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide.
    Doshi SN; Naka KK; Payne N; Jones CJ; Ashton M; Lewis MJ; Goodfellow J
    Clin Sci (Lond); 2001 Dec; 101(6):629-35. PubMed ID: 11724650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between shear stress and flow-mediated dilatation: implications for the assessment of endothelial function.
    Pyke KE; Tschakovsky ME
    J Physiol; 2005 Oct; 568(Pt 2):357-69. PubMed ID: 16051630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction.
    Meyer MF; Lieps D; Schatz H; Pfohl M
    Microvasc Res; 2008 May; 76(1):61-5. PubMed ID: 18448131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia.
    Martin EA; Nicholson WT; Eisenach JH; Charkoudian N; Joyner MJ
    J Appl Physiol (1985); 2006 Aug; 101(2):492-9. PubMed ID: 16614358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency regular exercise improves flow-mediated dilatation of subjects with mild hypertension.
    Moriguchi J; Itoh H; Harada S; Takeda K; Hatta T; Nakata T; Sasaki S
    Hypertens Res; 2005 Apr; 28(4):315-21. PubMed ID: 16138561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of shear stimulus, risk factor burden and early atherosclerosis on the time-course of brachial artery flow-mediated vasodilation.
    Chironi G; Craiem D; Miranda-Lacet J; Levenson J; Simon A
    J Hypertens; 2008 Mar; 26(3):508-15. PubMed ID: 18300862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise as an alternative to oral estrogen for amelioration of endothelial dysfunction in postmenopausal women.
    Harvey PJ; Picton PE; Su WS; Morris BL; Notarius CF; Floras JS
    Am Heart J; 2005 Feb; 149(2):291-7. PubMed ID: 15846267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of blood viscosity in the assessment of flow-mediated dilation and arterial stiffness.
    Parkhurst KL; Lin HF; Devan AE; Barnes JN; Tarumi T; Tanaka H
    Vasc Med; 2012 Aug; 17(4):231-4. PubMed ID: 22848085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The time course of flow-mediated vasodilation and endothelial dysfunction in patients with a cardiovascular risk factor.
    Kabutoya T; Hoshide S; Ogata Y; Iwata T; Eguchi K; Kario K
    J Am Soc Hypertens; 2012; 6(2):109-16. PubMed ID: 22321961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal systolic blood pressure during treadmill test and brachial artery flow-mediated vasodilatation impairment.
    Mirat J; Bernat R; Majdancić Z; Kolcić I; Galić E; Zeljko H; Bergovec M; Reiner Z
    Coll Antropol; 2007 Jun; 31(2):517-22. PubMed ID: 17847932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of blood pressure cuff inflation rates on flow-mediated dilatation and contralateral arm response.
    Lin HF; Dhindsa MS; Tarumi T; Miles SC; Umpierre D; Tanaka H
    J Hum Hypertens; 2012 Jan; 26(1):35-40. PubMed ID: 21248779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic plasma levels of nitrite/nitrate (NOx) reflect brachial flow-mediated dilation responses in young men and women.
    Casey DP; Beck DT; Braith RW
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1291-3. PubMed ID: 17973870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-dependent brachial artery flow-mediated vasodilatation in patients with diabetes mellitus with and without coronary artery disease.
    Nanivadekar A
    J Assoc Physicians India; 2004 Sep; 52():759-60; author reply 760. PubMed ID: 15839462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.